A. David Rodrigues

2.4k citations

49 papers · 1.8k indexed · h-index 26

Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 31
- Drug-Induced Hepatotoxicity and Protection 9
- Antibiotics Pharmacokinetics and Efficacy 4
Oncology top 5%
- Drug Transport and Resistance Mechanisms 31
Pediatrics, Perinatology and Child Health top 5%
- Pharmacological Effects and Toxicity Studies 12
Hepatology top 5%
Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
Molecular Biology
- Extracellular vesicles in disease 3
Spectroscopy
- Analytical Chemistry and Chromatography 3

Co-authors: Zheng Yang Michael Sinz Hongjian Zhang Andrew Rowland Yong–Hae Han Michael J. Sorich Jawaher Abdullah Alamoudi Cliff Chen
Cited by: Pharmacology Oncology Pediatrics, Perinatology and Child Health
Journals: Journal of Medicinal Chemistry (1 paper)Archives of Biochemistry and Biophysics (1 paper)Biochemical Pharmacology (1 paper)
Partner nations: United States Germany Australia

In The Last Decade

A. David Rodrigues

49 papers receiving 1.8k citations

Peers

Countries citing papers authored by A. David Rodrigues

Since Specialization

Citations

This map shows the geographic impact of A. David Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. David Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. David Rodrigues more than expected).

Fields of papers citing papers by A. David Rodrigues

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. David Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. David Rodrigues. The network helps show where A. David Rodrigues may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. David Rodrigues, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. David Rodrigues Line = papers co-authored together A. David Rodrigues links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles PROTEOMICS ·Zivile Useckaite,Lauren A. Newman,Ashley M. Hopkins,Sonja Klebe,Alex D. Colella,Nusha Chegeni,Ruth Williams,Michael J. Sorich,A. David Rodrigues,Tim Chataway,Andrew Rowland	2023	3
2	Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition Drug Metabolism and Disposition ·Zivile Useckaite,A. David Rodrigues,Ashley M. Hopkins,Lauren A. Newman,Jillian G. Johnson,Michael J. Sorich,Andrew Rowland	2021	15
3	Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by Clarithromycin The AAPS Journal ·Asha J. Kapetas,Ahmad Y. Abuhelwa,Michael J. Sorich,Ross A. McKinnon,A. David Rodrigues,Andrew Rowland,Ashley M. Hopkins	2021	10
4	Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate Frontiers in Pharmacology ·Madelé van Dyk,Asha J. Kapetas,Ashley M. Hopkins,A. David Rodrigues,Manoli Vourvahis,Michael J. Sorich,Andrew Rowland	2019	6
5	Plasma extracellular nanovesicle (exosome)‐derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure British Journal of Clinical Pharmacology ·Andrew Rowland,Warit Ruanglertboon,Madelé van Dyk,Dhilushi Wijayakumara,Linda S. Wood,Robyn Meech,Peter I. Mackenzie,A. David Rodrigues,Jean‐Claude Marshall,Michael J. Sorich	2018	62
6	Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanisticin vitroAssays Toxicological Sciences ·Falgun Shah,Louis Leung,Hugh A. Barton,Yvonne Will,A. David Rodrigues,Nigel Greene,Michael D. Aleo	2015	106
7	Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions Drug Metabolism and Disposition ·Yoshiyuki Shirasaka,Shu Ying Chang,Mary F. Grubb,Chi-Chi Peng,Kenneth E. Thummel,Nina Isoherranen,A. David Rodrigues	2013	27
8	Development of Novel, 384-Well High-Throughput Assay Panels for Human Drug Transporters: Drug Interaction and Safety Assessment in Support of Discovery Research SLAS DISCOVERY ·Huaping Tang,Ding Ren Shen,Yong–Hae Han,Yan Kong,Praveen Balimane,Anthony M. Marino,Mian Gao,Sophie Wu,Dianlin Xie,Matthew G. Soars,Jonathan C. O’Connell,A. David Rodrigues,Litao Zhang,Mary Ellen Cvijic	2013	13
9	Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump Drug Metabolism and Disposition ·A. David Rodrigues,Yurong Lai,Mary Ellen Cvijic,Lisa Elkin,Tatyana Zvyaga,Matthew G. Soars	2013	86
10	Development of a Carbon-14 Labeling Approach to Support Disposition Studies with a Pegylated Biologic Drug Metabolism and Disposition ·Haiqing Wang,Lifei Wang,Kai Cao,Stuart L. Emanuel,Paul E. Morin,Zheng Lin,Guoxiang Shen,Jennifer Hosbach,Donglu Zhang,Samuel J. Bonacorsi,A. David Rodrigues,Zheng Yang	2012	5
11	Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19 Drug Metabolism and Disposition ·Tatyana Zvyaga,Shu‐Ying Chang,Cliff Chen,Zheng Yang,Ragini Vuppugalla,Jeremy Hurley,Denise Thorndike,Andrew J. Wagner,Anjaneya Chimalakonda,A. David Rodrigues	2012	99
12	Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats Xenobiotica ·Ragini Vuppugalla,Yueping Zhang,Shu Chang,A. David Rodrigues,Punit H. Marathe	2012	10
13	Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Liver Drug Transporters Drug Metabolism and Disposition ·Yong–Hae Han,Dennis E. Busler,Hong Yang,Yuan Tian,Cliff Chen,A. David Rodrigues	2010	53
14	A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile Journal of Pharmaceutical and Biomedical Analysis ·Cliff Y. Chen,R. Marc Fancher,Qian Ruan,Punit Marathe,A. David Rodrigues,Zheng Yang	2008	16
15	Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol Clinical Pharmacokinetics ·Hongjian Zhang,Donghui Cui,Bonnie Wang,Yong–Hae Han,Praveen Balimane,Zheng Yang,Michael Sinz,A. David Rodrigues	2007	143
16	Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been? Pharmaceutical Research ·Christine Huang,Ming Zheng,Zheng Yang,A. David Rodrigues,Punit Marathe	2007	16
17	Prioritization of Clinical Drug Interaction Studies Using In Vitro Cytochrome P450 Data:“Rank Order” Approach Drug Metabolism Letters ·A. David Rodrigues	2007	16
18	Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase Archives of Biochemistry and Biophysics ·Bo Wen,Jed N. Lampe,Arthur G. Roberts,William M. Atkins,A. David Rodrigues,Sidney D. Nelson	2006	16
19	Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey European Journal of Pharmaceutical Sciences ·Magang Shou,Wei Lü,Prasad H. Kari,Cathie Xiang,Yuexia Liang,Ping Lü,Dan Cui,W. Bart Emary,Kimberly Michel,Jennifer K. Adelsberger,Janice Brunner,A. David Rodrigues	2005	21
20	Application of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions: In Vitro-in Vivo Correlations and the Abbott Laboratories Experience Advances in pharmacology ·A. David Rodrigues,Shekman Wong	1997	27

About A. David Rodrigues

A. David Rodrigues is a scholar working on Pharmacology, Oncology and Transplantation, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (31 papers), Pharmacological Effects and Toxicity Studies (12 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Extracellular vesicles in disease (3 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Pharmacology (924 citations), Oncology (772 citations) and Pediatrics, Perinatology and Child Health (328 citations). A. David Rodrigues has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Zheng Yang, Michael Sinz, Hongjian Zhang, Andrew Rowland, Yong–Hae Han, Michael J. Sorich, Jawaher Abdullah Alamoudi, Cliff Chen, Rhishikesh Thakare and Nagsen Gautam. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact